• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SLUG 通过抑制其泛素化作用导致乳腺癌细胞中 D1 周期蛋白水平升高。

SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.

机构信息

Department of Microbiology and Immunology, Meharry Medical College, Nashville, Tennessee 37208, USA. and.

出版信息

J Biol Chem. 2011 Jan 7;286(1):469-79. doi: 10.1074/jbc.M110.164384. Epub 2010 Nov 2.

DOI:10.1074/jbc.M110.164384
PMID:21044962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3013006/
Abstract

UbcH5c, a member of the UbcH5 family of protein ubiquitin conjugase E2 enzymes, is a critical component of biological processes in human cells, being the initial ubiquitinating enzyme of substrates like IκB, TP53, and cyclin D1. We report here that the metastasis regulator protein SLUG inhibits the expression of UbcH5c directly through chromatin remodeling and thus, among other downstream effects, elevates the level of cyclin D1, thus enhancing the growth rates of breast cancer cells. Overexpression of SLUG in the SLUG-deficient breast cancer cells significantly decreased the levels of mRNA and protein of UbcH5c but only elevated the protein levels of cyclin D1. On the contrary, knockdown of SLUG in SLUG-high breast cancer cells elevated the levels of UbcH5c while decreasing the level of cyclin D1 protein. SLUG is recruited at the E2-box sequence at the UbcH5c gene promoter along with the corepressor CtBP1 and the effector HDAC1 to silence the expression of this gene. Knockdown of UbcH5c in the SLUG-deficient human breast cells elevated the level of cyclin D1 as well as the rates of proliferation and invasiveness of these cells. Whereas the growth rates of the cells are enhanced due to overexpression of SLUG or knockdown of UbcH5c in the breast cancer cells tested, ER(+) cells also acquire resistance to the anti-estrogen 4-hydroxytamoxifen due to the rise of cyclin D1 levels in these cells. This study thus implicates high levels of SLUG and low levels of UbcH5c as a determinant in the progression of metastatic breast cancer.

摘要

UbcH5c 是泛素连接酶 E2 家族 UbcH5 的成员,是人类细胞中生物过程的关键组成部分,是 IκB、TP53 和 cyclin D1 等底物的初始泛素化酶。我们在这里报告,转移调节蛋白 SLUG 通过染色质重塑直接抑制 UbcH5c 的表达,因此,除了其他下游效应外,还会升高 cyclin D1 的水平,从而增强乳腺癌细胞的生长速度。在 SLUG 缺陷型乳腺癌细胞中过表达 SLUG 会显著降低 UbcH5c 的 mRNA 和蛋白水平,但仅升高 cyclin D1 蛋白水平。相反,在 SLUG 高表达的乳腺癌细胞中敲低 SLUG 会升高 UbcH5c 的水平,同时降低 cyclin D1 蛋白水平。SLUG 与核心抑制因子 CtBP1 和效应因子 HDAC1 一起募集到 UbcH5c 基因启动子的 E2 盒序列,从而沉默该基因的表达。在 SLUG 缺陷型人乳腺癌细胞中敲低 UbcH5c 会升高 cyclin D1 水平以及这些细胞的增殖和侵袭率。虽然在测试的乳腺癌细胞中过表达 SLUG 或敲低 UbcH5c 会增强细胞的生长速度,但由于这些细胞中 cyclin D1 水平的升高,ER(+) 细胞也对抗雌激素 4-羟基他莫昔芬产生了耐药性。因此,本研究表明高水平的 SLUG 和低水平的 UbcH5c 是转移性乳腺癌进展的决定因素。

相似文献

1
SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.SLUG 通过抑制其泛素化作用导致乳腺癌细胞中 D1 周期蛋白水平升高。
J Biol Chem. 2011 Jan 7;286(1):469-79. doi: 10.1074/jbc.M110.164384. Epub 2010 Nov 2.
2
High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG.三阴性乳腺癌细胞的高迁移性是由于转移调节蛋白 SLUG 对桥粒蛋白基因的抑制。
J Biol Chem. 2012 Jun 1;287(23):19472-86. doi: 10.1074/jbc.M112.345728. Epub 2012 Apr 11.
3
TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.TMPRSS4通过诱导Slug和细胞周期蛋白D1来诱导前列腺癌细胞的侵袭和增殖。
Oncotarget. 2016 Aug 2;7(31):50315-50332. doi: 10.18632/oncotarget.10382.
4
In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells.在人乳腺细胞中,SLUG对VDR基因启动子的体内结合及功能抑制
Biochem Biophys Res Commun. 2008 Jul 18;372(1):30-4. doi: 10.1016/j.bbrc.2008.04.187. Epub 2008 May 14.
5
Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.BRCA1表达降低通过改变雌激素受体-共调节因子相互作用赋予乳腺癌细胞对他莫昔芬的耐药性。
Oncogene. 2009 Jan 29;28(4):575-86. doi: 10.1038/onc.2008.405. Epub 2008 Nov 10.
6
Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression.slug 通过下调 cyclin D1 的表达抑制人前列腺癌细胞的增殖。
Prostate. 2010 Dec 1;70(16):1768-77. doi: 10.1002/pros.21213.
7
Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells.细胞周期蛋白D1是他莫昔芬诱导人乳腺癌细胞周期进程所必需的。
Cancer Res. 2006 Dec 1;66(23):11478-84. doi: 10.1158/0008-5472.CAN-06-1755.
8
Slug regulates Cyclin D1 expression by ubiquitin-proteasome pathway in prostate cancer cells.slug 通过泛素-蛋白酶体途径调节前列腺癌细胞中 cyclin D1 的表达。
Panminerva Med. 2012 Sep;54(3):219-23.
9
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.长链非编码 RNA DILA1 抑制细胞周期蛋白 D1 的降解,促进乳腺癌对他莫昔芬的耐药性。
Nat Commun. 2020 Nov 2;11(1):5513. doi: 10.1038/s41467-020-19349-w.
10
Curcumin suppresses 4-hydroxytamoxifen resistance in breast cancer cells by targeting SLUG/Hexokinase 2 pathway.姜黄素通过靶向SLUG/己糖激酶2通路抑制乳腺癌细胞对4-羟基他莫昔芬的耐药性。
Biochem Biophys Res Commun. 2016 Apr 22;473(1):147-153. doi: 10.1016/j.bbrc.2016.03.067. Epub 2016 Mar 21.

引用本文的文献

1
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance.O-连接的N-乙酰葡糖胺化(O-GlcNAcylation)与泛素化之间的相互作用:一种克服癌症治疗耐药性的新策略。
Exp Hematol Oncol. 2024 Nov 1;13(1):107. doi: 10.1186/s40164-024-00569-5.
2
SNAI2 as a Prognostic Biomarker Based on Cancer-Associated Fibroblasts in Patients With Lung Adenocarcinoma.基于肺腺癌患者癌症相关成纤维细胞的SNAI2作为一种预后生物标志物
Clin Med Insights Oncol. 2024 Sep 19;18:11795549241280506. doi: 10.1177/11795549241280506. eCollection 2024.
3
High-grade serous carcinoma of the fallopian tube in a young woman with chromosomal 4q abnormality: A case report.一名年轻女性患有4号染色体异常的高级别输卵管浆液性癌:病例报告
World J Clin Cases. 2024 Jun 26;12(18):3539-3547. doi: 10.12998/wjcc.v12.i18.3539.
4
E3 ligase MG53 suppresses tumor growth by degrading cyclin D1.E3 连接酶 MG53 通过降解细胞周期蛋白 D1 抑制肿瘤生长。
Signal Transduct Target Ther. 2023 Jul 7;8(1):263. doi: 10.1038/s41392-023-01458-9.
5
Snail-Family Proteins: Role in Carcinogenesis and Prospects for Antitumor Therapy.蜗牛家族蛋白:在肿瘤发生中的作用及抗肿瘤治疗前景
Acta Naturae. 2021 Jan-Mar;13(1):76-90. doi: 10.32607/actanaturae.11062.
6
The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy.泛素连接酶(E2s)作为癌症治疗潜在靶点的分子基础。
Int J Mol Sci. 2021 Mar 26;22(7):3440. doi: 10.3390/ijms22073440.
7
SUMO-Modification of Human Nrf2 at K and K Regulates Its Nucleocytoplasmic Localization, Stability and Transcriptional Activity.SUMO 修饰人 Nrf2 的 K 和 K 调节其核质定位、稳定性和转录活性。
Cell Physiol Biochem. 2021 Mar 27;55(2):141-159. doi: 10.33594/000000351.
8
Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.基质 SNAI2 对于 ERBB2 乳腺癌的进展是必需的。
Cancer Res. 2020 Dec 1;80(23):5216-5230. doi: 10.1158/0008-5472.CAN-20-0278. Epub 2020 Oct 6.
9
CircRNA-0008717 promotes cell proliferation, migration, and invasion by regulating miR-203/Slug in esophageal cancer cells.环状RNA-0008717通过调控食管癌细胞中的miR-203/Slug促进细胞增殖、迁移和侵袭。
Ann Transl Med. 2020 Aug;8(16):999. doi: 10.21037/atm-20-5205.
10
ASB13 inhibits breast cancer metastasis through promoting SNAI2 degradation and relieving its transcriptional repression of YAP.ASB13 通过促进 SNAI2 降解并解除其对 YAP 的转录抑制作用来抑制乳腺癌转移。
Genes Dev. 2020 Oct 1;34(19-20):1359-1372. doi: 10.1101/gad.339796.120. Epub 2020 Sep 17.

本文引用的文献

1
SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation.SCF(细胞周期蛋白 F)通过降解 CP110 来控制中心体稳态和有丝分裂保真度。
Nature. 2010 Jul 1;466(7302):138-42. doi: 10.1038/nature09140.
2
The 26S proteasome: assembly and function of a destructive machine.26S 蛋白酶体:破坏机器的组装和功能。
Trends Biochem Sci. 2010 Nov;35(11):634-42. doi: 10.1016/j.tibs.2010.05.005. Epub 2010 Jun 10.
3
Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate.引发和延伸:SCF 底物上多泛素化的 UbcH5/Cdc34 E2 交接机制。
Mol Cell. 2010 Mar 26;37(6):784-96. doi: 10.1016/j.molcel.2010.02.025.
4
The potential role of ubiquitin c-terminal hydrolases in oncogenesis.泛素羧基末端水解酶在肿瘤发生中的潜在作用。
Biochim Biophys Acta. 2010 Aug;1806(1):1-6. doi: 10.1016/j.bbcan.2010.03.001. Epub 2010 Mar 17.
5
The regulatory crosstalk between kinases and proteases in cancer.癌症中激酶和蛋白酶的调控串扰。
Nat Rev Cancer. 2010 Apr;10(4):278-92. doi: 10.1038/nrc2823. Epub 2010 Mar 19.
6
Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.细胞周期依赖性调节人类乳腺癌细胞中 BRCA2/ZAR2 基因的双向重叠启动子。
Mol Cancer. 2010 Mar 4;9:50. doi: 10.1186/1476-4598-9-50.
7
Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.通过破坏泛素酶复合物抑制 NF-κB 信号转导。
Science. 2010 Feb 26;327(5969):1135-9. doi: 10.1126/science.1182364.
8
SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts.SLUG 是人类成骨细胞中淋巴增强因子-1 的一个新靶点。
BMC Mol Biol. 2010 Feb 3;11:13. doi: 10.1186/1471-2199-11-13.
9
E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.E3泛素连接酶COP1调节MTA1的稳定性和功能。
Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17493-8. doi: 10.1073/pnas.0908027106. Epub 2009 Sep 24.
10
Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.E-钙黏蛋白、Slug和糖原合成酶激酶3β在乳腺浸润性导管癌中的表达分析
BMC Cancer. 2009 Sep 14;9:325. doi: 10.1186/1471-2407-9-325.